Chemomab Therapeutics Ltd. buy Global_Player
Start price
24.03.25
/
50%
€1.14
Target price
24.03.26
-
Performance (%)
-12.72%
End price
29.03.25
€1.00
Summary
This prediction ended on 29.03.25 with a price of €1.00. The price of Chemomab Therapeutics Ltd. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.72%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Chemomab Therapeutics Ltd. | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to Global_Player what are the pros and cons of Chemomab Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Chemomab Therapeutics Ltd. diskutieren
Buy Chemomab Therapeutics Ltd.
In the thread Trading Chemomab Therapeutics Ltd.
Stopped prediction by Global_Player for Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.10
18.06.25
18.06.25
-
18.06.26
18.06.26
-3.64%
21.06.25
21.06.25
Could be worthwhile Investment >10% per year
Chemomab Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.23
04.03.25
04.03.25
-
04.03.26
04.03.26
6.50%
15.03.25
15.03.25
Chemomab Therapeutics Ltd.
Start price
Target price
Perf. (%)
€2.12
19.01.25
19.01.25
-
19.01.26
19.01.26
-6.60%
01.02.25
01.02.25